"Established in 2004, The Research Group of Lexington (TRG) is an independent research firm focused in partnering to develop medications for tomorrow. Clinical research is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease."

During the past decade, The Research Group of Lexington LLC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Research Group of Lexington LLC" #1 sponsor was "Kowa Research Institute, Inc." with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored and "Arrowhead Pharmaceuticals" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Research Group of Lexington LLC" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Research Group of Lexington LLC" are "Severe Hypertriglyceridemia" (4 trials), "Cardiovascular Disease" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "The Research Group of Lexington LLC" in a lesser frequency.

Most popular intervention types in "The Research Group of Lexington LLC" are "Drug" (14 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "K-877" (3 trials), "Fenofibrate" (2 trials), "Placebo (for K-877)" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Research Group of Lexington LLC" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Research Group of Lexington LLC". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Research Group of Lexington LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Research Group of Lexington LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".